Expression of manganese superoxide dismutase in esophageal and gastric cancers

Journal of Gastroenterology

Volumn 33, Issue 6, 1998, Pages 816-822

  Izutani, Ryo ^a   Asano, Satoshi ^a   Imano, Motohiro ^a   Kuroda, Daisuke ^a   Kato, Michio ^a   Ohyanagi, Harumasa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Gastric cancer; MnSOD; PCR

Indexed keywords

ANTIOXIDANT; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

ADENOCARCINOMA; AGED; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; REFERENCE VALUES; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; SUPEROXIDE DISMUTASE;

EID: 0032458363     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050181     Document Type: Article

References (28)

1. Sugimachi K, Watanabe M, Sadanaga N, et al. Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 1994;178:363-368.
2. Akoh JA, Macintyre IMC. Improving survival in gastric cancer: Review of 5-year survival rates in English language publications from 1970. Br J Surg 1992;79:293-299.
3. Gottesmann MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
4. Izutani R, Katoh M, Asano S, et al. Enhanced expression of manganese superoxide disumutase mRNA and increased TNFα mRNA expression by gastric mucosa in gastric cancer. World J Surg 1996;20:228-233.
5. Halliwell B, Hoult JR, Blake DR. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J 1998;2:2867-2873.
6. Richter C, PARK J-W, AMES BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988;85:6465-6467.
7. Fridovich I. The biology of oxygen radicals. Science 1978;201:875-880.
8. Tsuji Y, Watanabe N, Okamoto T, et al. Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity. Cancer Res 1992;52:6258-6262.
9. Chomczynnski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 1987;162:156.
10. Beck Y, Oren R, Amit B, et al. Human Mn superoxide disumutase cDNA sequence. Nucleic Acids Res 1989;15:9076.
11. Nishida S, Akai F, Iwasaki H, et al. Manganese superoxide disumutase content and localization in human thyroid tumors. J Pathol 1993;169:341-345.
12. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:34-49.
13. Westman NG, Marklund SL. Copper- and zinc-containing superoxide disumutase and manganese-containing superoxide disumutase in human tissues and human malignant tumors. Cancer Res 1981;41:2962-2966.
14. Warner BB, Burhans MS, Clark JC, et al. Tumor necrosis factor-α increases Mn-SOD expression: Protection against oxidant injury. Am J Physiol 1991;260:L296-301.
15. Niitu Y, Takahashi Y, Saito T, et al. Serum GST-π as a tumor marker for gastrointestinal malignancies. Cancer 1988;63:317-323.
16. Hirata S, Odajima T, Kohama G, et al. Significance of glutathione S-transferase-π as a tumor marker in patients with oral cancer. Cancer 1992;70:2381-2387.
17. Hida T, Ariyoshi Y, Kuwabata M, et al. Glutathione S-transferase levels in panel of lung cancer cell lines and relation to chemoradiosensitivity. Jpn J Clin Oncol 1993;23:14-19.
18. Satomi A, Murakami S, Hashimoto T, et al. Estimation of serum tumor necrosis factor-α and tumor tissue superoxide disumutase activity in the prognosis of human colorectal cancer. Int J Clin Oncol 1997;2:15-20.
19. Iizuka S, Taniguchi N, Makita A. Enzyme-linked immunosorbent assay for human manganese-containing superoxide disumutase and its contents in lung cancer. J Natl Cancer Inst 1984;72:1043-1049.
20. Ishikawa M, Yaginuma Y, Hayashi H, et al. Reactivity of a monoclonal antibody to manganese superoxide disumutase with human ovarian carcinoma. Cancer Res 1990;50:2538-2542.
21. Cobbs CS, Levi DS, Aldape K, et al. Manganese superoxide disumutase expression in human central nervous system tumors. Cancer Res 1996;56:3192-3195.
22. Kizaki M, Sakashita A, Karmakar A, et al. Regulation of manganese superoxide disumutase and other antioxidant genes in normal and leukemic hematopoietic cells and their relationship to cytotoxicity by tumor necrosis factor. Blood 1993;82:1142-1150.
23. Nakano T, Oka K, Taniguchi N. Manganese superoxide disumutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res 1996;56:2771-2775.
24. Kato M, Izutani R, Yasuda C, et al. Relationship between expression of P-glycoprotein and histological type of stomach cancer. In: Nishi M (ed) First International gastric cancer congress; international proceedings division. Bologna, Italy: Monduzzi Editore, 1995;917-921.
25. Hirose K, Matsushima K. The biological significance of the induction of manganese superoxide disumutase by interleukin 1 and tumor necrosis factor (in Japanese with English abstract). In: Kondo M (ed) Free radicals in clinical medicine. Tokyo: Nihon-Igakukan, 1993;71-77.
26. Nakadi IEL, Houben J-J, Gay F, et al. Does esophagectomy cure a resectable esophageal cancer. World J Surg 1993;17:760-765.
27. Sasano H, Miuazaki S, Shige K, et al. Gluthathione S-transferase in human esophageal carcinoma. Anticancer Res 1993;13:363-368.
28. Taniguchi N, Ishikawa M, Kawaguchi T, et al. Expression of Mn-superoxide disumutase in carcinogesis. Tohoku J Exp Med 1992;168:105-111.